Bevacizumab for CRVO Associated CME: Effect of Timing and Frequency of Injections on Final Visual Outcome

Purpose. Injection of anti-VEGF antibody into the vitreous body is a well-established treatment for ischemic central retinal vein occlusion (CRVO) associated macular edema. Various treatment regimens regarding the timing, number, and frequency of injections have been proposed. Methods. We reviewed t...

Descripción completa

Detalles Bibliográficos
Autores principales: Pikkel, Joseph, Chassid, Otzem, Busool, Yumna, Srour, Ward, Sharabi-Nov, Adi, Beiran, Itzchak
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3893752/
https://www.ncbi.nlm.nih.gov/pubmed/24490054
http://dx.doi.org/10.1155/2013/974670

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3893752/
https://www.ncbi.nlm.nih.gov/pubmed/24490054
http://dx.doi.org/10.1155/2013/974670

Ejemplares similares